Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis.

Vedantham S, Goldhaber SZ, Julian JA, Kahn SR, Jaff MR, Cohen DJ, Magnuson E, Razavi MK, Comerota AJ, Gornik HL, Murphy TP, Lewis L, Duncan JR, Nieters P, Derfler MC, Filion M, Gu CS, Kee S, Schneider J, Saad N, Blinder M, Moll S, Sacks D, Lin J, Rundback J, Garcia M, Razdan R, VanderWoude E, Marques V, Kearon C; ATTRACT Trial Investigators.

N Engl J Med. 2017 Dec 7;377(23):2240-2252. doi: 10.1056/NEJMoa1615066.

PMID:
29211671
2.

Breast Cancer Subtype Influences the Accuracy of Predicting Pathologic Response by Imaging and Clinical Breast Exam After Neoadjuvant Chemotherapy.

Waldrep AR, Avery EJ, Rose FF Jr, Midathada MV, Tilford JA, Kolberg HC, Hutchins MR.

Anticancer Res. 2016 Oct;36(10):5389-5395.

PMID:
27798904
3.

Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma.

Stewart AK, Rajkumar SV, Dimopoulos MA, Masszi T, Špička I, Oriol A, Hájek R, Rosiñol L, Siegel DS, Mihaylov GG, Goranova-Marinova V, Rajnics P, Suvorov A, Niesvizky R, Jakubowiak AJ, San-Miguel JF, Ludwig H, Wang M, Maisnar V, Minarik J, Bensinger WI, Mateos MV, Ben-Yehuda D, Kukreti V, Zojwalla N, Tonda ME, Yang X, Xing B, Moreau P, Palumbo A; ASPIRE Investigators.

N Engl J Med. 2015 Jan 8;372(2):142-52. doi: 10.1056/NEJMoa1411321. Epub 2014 Dec 6.

4.

A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias.

Cortes JE, Kim DW, Pinilla-Ibarz J, le Coutre P, Paquette R, Chuah C, Nicolini FE, Apperley JF, Khoury HJ, Talpaz M, DiPersio J, DeAngelo DJ, Abruzzese E, Rea D, Baccarani M, Müller MC, Gambacorti-Passerini C, Wong S, Lustgarten S, Rivera VM, Clackson T, Turner CD, Haluska FG, Guilhot F, Deininger MW, Hochhaus A, Hughes T, Goldman JM, Shah NP, Kantarjian H; PACE Investigators.

N Engl J Med. 2013 Nov 7;369(19):1783-96. doi: 10.1056/NEJMoa1306494. Epub 2013 Nov 1.

5.

The Stanford V regimen is effective in patients with good risk Hodgkin lymphoma but radiotherapy is a necessary component.

Abuzetun JY, Loberiza F, Vose J, Bierman P, Bociek RG, Enke C, Bast M, Weisenburger D, Armitage JO; Nebraska Lymphoma Study Group.

Br J Haematol. 2009 Feb;144(4):531-7. doi: 10.1111/j.1365-2141.2008.07500.x. Epub 2008 Nov 26.

PMID:
19055670
6.

Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes.

Govindarajan R, Ratnasinghe L, Simmons DL, Siegel ER, Midathada MV, Kim L, Kim PJ, Owens RJ, Lang NP.

J Clin Oncol. 2007 Apr 20;25(12):1476-81.

PMID:
17442990
7.

Ocular melanoma versus ocular metastasis: a diagnostic dilemma.

Midathada M, Safar A, Schaefer R, Viswamitra S, Kohli M.

Clin Adv Hematol Oncol. 2005 May;3(5):425-7. No abstract available.

PMID:
16167017
8.

Recombinant factor VIIa in the treatment of bleeding.

Midathada MV, Mehta P, Waner M, Fink LM.

Am J Clin Pathol. 2004 Jan;121(1):124-37. Review.

PMID:
14750250
9.

Natural T, gammadelta, and NK cells in mycobacterial, Salmonella, and human immunodeficiency virus infections.

Jason J, Buchanan I, Archibald LK, Nwanyanwu OC, Bell M, Green TA, Eick A, Han A, Razsi D, Kazembe PN, Dobbie H, Midathada M, Jarvis WR.

J Infect Dis. 2000 Aug;182(2):474-81. Epub 2000 Jul 18.

PMID:
10915078

Supplemental Content

Loading ...
Support Center